Copyright
©The Author(s) 2024.
World J Gastrointest Surg. Nov 27, 2024; 16(11): 3463-3470
Published online Nov 27, 2024. doi: 10.4240/wjgs.v16.i11.3463
Published online Nov 27, 2024. doi: 10.4240/wjgs.v16.i11.3463
Table 2 Comparison of patients’ baseline data after matching, n (%)
| Variable | Group A (n = 86) | Group B (n = 86) | χ2/t | P value |
| Sex | 0.214 | 0.643 | ||
| Male | 51 (59.30) | 48 (55.81) | ||
| Female | 35 (40.70) | 38 (44.19) | ||
| Age (years), mean ± SD | 54.36 ± 8.37 | 53.84 ± 8.45 | 0.408 | 0.684 |
| Child-Pugh grading | 8.331 | 0.004 | ||
| Grade A | 44 (51.12) | 44 (51.12) | 0.000 | 1.000 |
| Grade B | 42 (48.84) | 42 (48.84) | ||
| TNM stage | 0.023 | 0.879 | ||
| Stage III | 46 (53.49) | 45 (52.33) | ||
| Stage IV | 40 (46.51) | 41 (47.67) | ||
| ECOG score (score) | 0.024 | 0.878 | ||
| 0-1 | 48 (55.81) | 49 (56.98) | ||
| 2 | 38 (44.19) | 37 (43.02) |
- Citation: Cheng XB, Yang L, Lu MQ, Peng YB, Wang L, Zhu SM, Hu ZW, Wang ZL, Yang Q. Clinical study of different interventional treatments for primary hepatocellular carcinoma based on propensity-score matching. World J Gastrointest Surg 2024; 16(11): 3463-3470
- URL: https://www.wjgnet.com/1948-9366/full/v16/i11/3463.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i11.3463